Upgrade to SI Premium - Free Trial

Catalyst Pharmaceuticals (CPRX)

31.27 -0.02 (0.06%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Form 4 CATALYST PHARMACEUTICALS For: Jun 03 Filed by: Andrews William T. June 5, 2026 5:01 PM - SEC Filing Form PREM14A CATALYST PHARMACEUTICALS For: May 28 May 28, 2026 5:49 PM - SEC Filing H.C. Wainwright Downgrades Catalyst Pharmaceutical Partners (CPRX) to Neutral May 28, 2026 10:23 AM - StreetInsider Form DEFA14A CATALYST PHARMACEUTICALS May 12, 2026 9:05 AM - SEC Filing Form 8-K CATALYST PHARMACEUTICALS For: May 11 May 11, 2026 4:35 PM - SEC Filing Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results May 11, 2026 4:12 PM - Globe NewsWire Form 10-Q CATALYST PHARMACEUTICALS For: Mar 31 May 11, 2026 4:11 PM - SEC Filing Form DEFA14A CATALYST PHARMACEUTICALS May 8, 2026 5:21 PM - SEC Filing Citi Downgrades Catalyst Pharmaceutical Partners (CPRX) to Neutral May 8, 2026 10:05 AM - StreetInsider Form DEFA14A CATALYST PHARMACEUTICALS May 7, 2026 5:28 PM - SEC Filing Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast May 7, 2026 4:02 PM - Globe NewsWire Oppenheimer Downgrades Catalyst Pharmaceutical Partners (CPRX) to Perform May 7, 2026 12:40 PM - StreetInsider Form DEFA14A CATALYST PHARMACEUTICALS May 7, 2026 9:01 AM - SEC Filing Form 8-K CATALYST PHARMACEUTICALS For: May 06 May 7, 2026 8:46 AM - SEC Filing Stephens Downgrades Catalyst Pharmaceutical Partners (CPRX) to Equal Weight May 7, 2026 8:02 AM - StreetInsider Catalyst Pharmaceuticals settles FIRDAPSE patent case with Hetero Labs May 7, 2026 5:59 AM - StreetInsider Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1 billion May 7, 2026 3:25 AM - StreetInsider Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease May 7, 2026 3:25 AM - Globe NewsWire Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd. May 7, 2026 2:44 AM - Globe NewsWire Angelini Pharma to acquire Catalyst Pharmaceuticals for $4.1 billion May 7, 2026 2:14 AM - StreetInsider Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease May 7, 2026 2:14 AM - StreetInsider Form 10-K/A CATALYST PHARMACEUTICALS For: Dec 31 April 30, 2026 4:32 PM - SEC Filing Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026 April 28, 2026 8:03 AM - Globe NewsWire BofA Securities stays Buy on Catalyst Pharma (CPRX) amid Angelini acquisition interest reports April 27, 2026 4:15 PM - StreetInsider Catalyst Pharmaceuticals (CPRX) 3600 contracts of May 30 calls trade, share price up 7.9% April 27, 2026 3:36 PM - StreetInsider Italy's Angelini Said To Explore Acquisition Of Catalyst Pharma - Bloomberg April 27, 2026 12:05 PM - StreetInsider Catalyst Pharmaceuticals (CPRX) 1500 contracts of September 30 calls trade April 14, 2026 2:12 PM - StreetInsider Form SCHEDULE 13G/A CATALYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 26, 2026 4:45 PM - SEC Filing Form 8-K/A CATALYST PHARMACEUTICALS For: Mar 18 March 19, 2026 6:05 AM - SEC Filing Form 8-K CATALYST PHARMACEUTICALS For: Mar 18 March 18, 2026 5:15 PM - SEC Filing Full Article List